No price history available.

Not enough data to calculate KvantraRank

Based on consensus from external analysts. Not Kvantra's opinion.

Bure Equity AB (publ), a private equity and venture capital firm established on November 23, 1992, and headquartered in Stockholm, Sweden, pursues a wide range of investment strategies. The firm adopts a flexible approach, targeting both publicly traded and privately held small and medium-sized enterprises (SMEs) within knowledge-intensive service industries. Its investment scope is comprehensive, covering various stages from early-stage and growth capital to mature buyouts, recapitalizations, special situations, and even specific funding methods like secondary direct, PIPES, and bridge financing. Bure Equity primarily focuses its investments, typically ranging from $5 million to $100 million, within developed Nordic and European markets. It diversifies its portfolio across numerous sectors, including education, communication, medical technology, consumer goods, financial services, industrial production, healthcare, information technology, and professional services. The firm aims to be a leading shareholder, acquiring majority stakes and exerting significant control over its investee companies. While not having a rigid divestment plan, it generally holds investments for a timeframe of three to five years, utilizing its own balance sheet for funding.

• Pantheon International PLC
• MFF Capital Investments Limited
• Corporación Financiera Colombiana S.A.
• HBM Healthcare Investments AG
• The Law Debenture Corporation p.l.c.
• Fairfax India Holdings Corporation
• Gimv N.V.
• Tri-Continental Corporation PFD $2.50